India Launches Late-Stage Study of Russian Coronavirus Vaccine

Dr. Reddy’s Laboratories Ltd. and the Russian Direct Investment Fund announced they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli, India. This will be a multicenter and randomized controlled study, which will include a safety and immunogenicity study.

G V Prasad, Co-chairman and Managing Director, Dr. Reddy’s Laboratories said in a press release issued on December 1, 2020: “We are working towards making the vaccine available with a combination of import and indigenous production model.”